Alex Goldberg

NASDAQ Gainers Watch List: Hologic Inc. (NASDAQ:HOLX) and Amarin Corporation Plc (NASDAQ:AMRN) Added to Equity Profile Report's NASDAQ Gainers Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 12/02/2013 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Hologic Inc. (NASDAQ:HOLX) and Amarin Corporation plc (NASDAQ:AMRN).

Hologic Inc. (NASDAQ:HOLX) a company that develops, manufactures, and supplies diagnostics, medical imaging systems, and surgical products for women is currently up (+0.42%) on 1,449,334 shares traded. Hologic Inc. (NASDAQ:HOLX) is currently up (+21.89%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Hologic Inc. (NASDAQ:HOLX)

Amarin Corporation plc (NASDAQ:AMRN) a biopharmaceutical company that focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases is currently up (+2.74%) on 3,560,323 shares traded after Amarin Announced Notification of Patent Allowances for U.S. Applications 13/685,281, and 13/685,291 Related to Triglyceride Lowering With a Mixture of Omega-3 Free Fatty Acid in Both the MARINE and ANCHOR Patient. Amarin Corporation plc (NASDAQ:AMRN) is currently up (+44.85%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Amarin Corporation plc (NASDAQ:AMRN)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com